Citadel Advisors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Citadel Advisors’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-17,900	Closed	-$431K	–	8802
2014 Q2	$431K	Buy	17,900 +16,400	+1,093%	+$171K	﹤0.01%	4597
2014 Q1	$9K	Sell	1,500 -3,000	-67%	-$20.9K	﹤0.01%	7564
2013 Q4	$27K	Sell	4,500 -2,800	-38%	-$13K	﹤0.01%	6318
2013 Q3	$38K	Buy	7,300 +3,300	+83%	+$14.5K	﹤0.01%	5937
2013 Q2	$14K	Buy	+4,000	New	+$16.4K	﹤0.01%	6163

Citadel Advisors's IDIX Position: Q3 2014 in Review

Citadel Advisors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 14,069 shares — an estimated $339K sold.

Citadel Advisors first reported a position in IDIX in Q2 2013 and held it in 4 quarters. The position peaked at $6.55M in Q1 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Citadel Advisors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Citadel Advisors sold 14,069 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $339K.
Citadel Advisors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
Citadel Advisors's IDENIX PHARMACEUTICALS INC position peaked at $6.55M in Q1 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Citadel Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.